Cargando…
A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer
BACKGROUND: Given malignant ascites with a terrible prognosis and a unique immune microenvironment, our purpose is to evaluate whether oncolytic herpes simplex virus type 2(OH2) is able to safely eliminate ascites of colon cancer and through which specific mechanism it exerts antitumor immunity. MET...
Autores principales: | Dong, Shuang, Liu, Binlei, Hu, Sheng, Guo, Fang, Zhong, Yi, Cai, Qian, Zhang, Siqi, Qian, Yu, Wang, Jun, Zhou, Fuxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678102/ https://www.ncbi.nlm.nih.gov/pubmed/35510373 http://dx.doi.org/10.1002/cam4.4772 |
Ejemplares similares
-
Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022) -
Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021) -
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response
por: Zhang, Yalei, et al.
Publicado: (2022) -
Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020) -
A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy
por: Hu, Han, et al.
Publicado: (2022)